C-Glycosides are
metabolically stable mimics of
natural O-glycosides and are expected to be useful
tools for investigation of the biological functions of glycans. Here,
we describe the synthesis of a series of aryl and vinyl C-glycosides by stereoinvertive sp3–sp2 cross-coupling reactions of 2-deoxyglycosyl boronic acid derivatives
with aryl or vinyl halide, mediated by a photoredox/nickel dual catalytic
system. Hydrogenation of the vinyl C-glycosides afforded
C-linked 2′-deoxydisaccharide analogues.
Seven mono- and dihydroxycholesterols were prepared by direct C–H oxidation of the cholestane skeleton with a recently developed Ru(Bpga) catalyst (Ru(Bpga) = [RuCl (bpga) (PPh3)] Cl; bpga = 2-(bis(pyridin-2-ylmethyl)amino)-N-(2,6-dimethylphenyl)acetamide)). Due to the high selectivity of the Ru(Bpga) complex for tertiary C–H, the reaction afforded a mixture of 25-, 20-, 17-, and 14-oxygenated cholesterols that could be easily separated by high-performance liquid chromatography. These results suggest that late-stage C–H oxidation could be a viable strategy for preparing candidate metabolites of biologically important molecules.
C-Glycoside analogues of native glycans are useful molecular tools for medicinal chemistry and chemical biology due to their resistance to cellular glycoside hydrolases. Previously we reported an α-selective direct C-glycosylation of 2-deoxy-β-glycosyl boronate via Ni/photoredox-catalyzed stereoinvertive cross-coupling reaction. Here we report a complementary stereoretentive synthetic methodology for preparation of β-C-glycosides from a similar boronate precursor via addition of Csp2 anion followed by 1,2-migration of the glycosyl donor.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.